|
市場調査レポート
商品コード
1535299
バイオ医薬品加工機器と消耗品の市場規模、シェア、予測、製品タイプ別、用途別、動向分析-2031年までの世界の予測Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type, Application - Global Forecast to 2031 |
||||||
カスタマイズ可能
|
バイオ医薬品加工機器と消耗品の市場規模、シェア、予測、製品タイプ別、用途別、動向分析-2031年までの世界の予測 |
出版日: 2024年08月14日
発行: Meticulous Research
ページ情報: 英文 294 Pages
納期: 即納可能
![]() |
バイオ医薬品加工機器と消耗品市場:製品タイプ別(ろ過、クロマトグラフィー、バイオリアクター、細胞培養液、シェーカー、サービス)、用途別(ワクチン、mAb、研究開発)-2031年までの市場規模、シェア、予測、動向分析
世界のバイオ医薬品加工機器と消耗品市場は、2023年に363億8,000万米ドルと評価されました。この市場は、2024年の推定402億2,000万米ドルから2031年には757億2,000万米ドルに達すると予測され、2024年から2031年の予測期間中のCAGRは9.5%です。
広範な2次調査と1次調査、市場シナリオの綿密な分析を経て、当レポートは主要な業界促進要因・抑制要因・課題・機会を特定しています。この市場の成長は、バイオ医薬品市場の成長、バイオ医薬品プラントの能力拡張、シングルユースバイオプロセシング機器の採用増加によって牽引されます。さらに、新興国、バイオプロセシング4.0へのシフト、個別化医薬品の採用の高まりは、この市場の利害関係者に成長機会をもたらすと期待されています。
本レポートには、市場参入企業が過去3年間(2021-2024年)に採用した主な戦略的発展の広範な評価に基づく競合情勢が含まれています。バイオ医薬品加工機器と消耗品の世界市場レポートにおいてプロファイルされている主要企業には、3M Company(米国)、Bio-Rad Laboratories, Inc(米国)、Thermo Fisher Scientific Inc(米国)、Danaher Corporation(米国)、Agilent Technologies, Inc(米国)、Repligen Corporation(米国)、Sartorius AG(ドイツ)、Merck KGaA(ドイツ)、Eppendorf AG(ドイツ)、Solaris Biotechnology Srl(イタリア)があります。
Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D)-Forecast to 2031
The global biopharmaceutical processing equipment and consumables market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.
After extensive secondary and primary research and in-depth analysis of the market scenario, the report identifies the key industry drivers, restraints, challenges, and opportunities. This market's growth is driven by the growing biopharmaceuticals market, biopharmaceutical plant capacity expansions, and the rising adoption of single-use bioprocessing equipment. Furthermore, emerging economies, the shift toward Bioprocessing 4.0, and the rising adoption of personalized medicines are expected to generate growth opportunities for the stakeholders in this market.
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years (2021-2024). The key players profiled in the global biopharmaceutical processing equipment and consumables market report are 3M Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2024, at 22.3%. The filtration systems are used repeatedly at every stage of the bioprocessing process, and their technological developments and repeatability are the main reasons contributing to the highest share. The development of single-use filtration systems and enhanced filtration titers are the primary areas of technological innovation in filtration.
Based on application, the market is segmented into commercial bioproduction and research bioproduction. In 2024, The commercial bioproduction segment is estimated to account for the larger share of 77.5% of the global biopharmaceutical processing equipment and consumables market to meet the growing demand for biopharmaceuticals. Biopharmaceutical companies are expanding their production capacities, developing new facilities, and moving to emerging biopharmaceutical hubs like India and Singapore, further accelerating the demand for biopharmaceutical processing equipment.
Based on end user, the global biopharmaceutical processing equipment and consumables market is categorized into pharmaceutical & biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic & research institutes. The biopharmaceutical processing equipment and consumables market is expected to be dominated by the pharmaceutical & biopharmaceutical firms sector by 2024. The growing demand for biopharmaceutical goods has led to a notable surge in growth for pharmaceutical and biopharmaceutical companies in recent times, with the latter holding the biggest part of the market. The largest share of the market is also supported by initiatives taken by governments in various nations, which include funding and grants to pharmaceutical and biopharmaceutical companies for the production and R&D of biopharmaceuticals and an increase in facility expansion by major players.
An in-depth analysis of the geographical scenario of the biopharmaceutical processing equipment and consumables market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) and covers major countries in each region.
In 2024, Europe is estimated to command the largest share of the 33.5% biopharmaceutical processing equipment and consumables market, followed by North America, Asia-Pacific, Latin America, and Middle East & Africa. The availability of top producers of consumables and equipment for biopharmaceutical processing, rising drug sales, encouragement from regulatory and governmental bodies to use biopharmaceuticals for a range of medical conditions, and a number of businesses growing both their production and operational capabilities.
Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type
Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors.
Global Biopharmaceutical Processing Equipment and Consumables Market, by Application
Global Biopharmaceutical Processing Equipment and Consumables Market, by End User
Global Biopharmaceutical Processing Equipment and Consumables Market, by Geography